Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects
- Status
- COMPLETED
- Phase
- PHASE1
BI 409306 Cardiac Safety Trial in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A
Safety Study of Afatinib for Brain Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
- Status
- COMPLETED
- Phase
- PHASE1
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.
- Status
- COMPLETED
- Phase
- PHASE1
BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
Canadian Pradaxa Acute Stroke Safety Study
- Status
- COMPLETED
- Phase
- N/A
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
- Status
- COMPLETED
- Phase
- PHASE3
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Asthma Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- N/A
Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)
- Status
- TERMINATED
- Phase
- PHASE2
Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China
- Status
- UNKNOWN
- Phase
- N/A
Trial of Afatinib in Pediatric Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809
- Status
- COMPLETED
- Phase
- PHASE1